Advertisement
Screener

Protara Therapeutics, Inc. (TARA) Gross Margin

Protara Therapeutics, Inc. (TARA) Gross Margin

  • Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2014-12-31..

Gross margin

Overview →

Financial period ending 2014-12-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Gross margin · 12 months(m)Gross profit / revenue. Period ending 2014-12-31.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Gross profit(m)
Revenue2.95M USD
Cost of products and services(m)

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingGross profit (USD)Revenue (USD)Cost of products and services (USD)Gross margin
2014-12-31(m)$2.95M(m)(m)
2014-09-30(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Alector, Inc. (ALEC)United States$0.213B-1.90
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90